Neosonics

Neosonics© is a first-in-class medical device that non-invasively counts white blood cells in serous fluid, enabling fast, easy and cost-effective screening, diagnosis and monitoring of serous fluid infections. It combines high-resolution ultrasound, unique coupling materials, and deep learning AI algorithms. EARLY DETECTION OF SEROUS FLUID INFECTIONS Infections occurring in serous fluids of the body are difficult to suspect and can cause death in a matter of hours or cause life-long disabilities among survivors if not detected promptly. These devastating diseases can present with very unspecific symptoms or signs challenging early and accurate diagnosis, which worsens the prognosis of the disease. Some of these potentially aggressive infections and inflammatory conditions are: Peritoneal Dialysis-related Peritonitis, Infant Meningitis, Uveitis, Septic Arthritis, Chorioamnionitis or Pleuritis among others. Thus, the global need we are addressing is the early, quick, easy and cost-efficient detection of serous fluid infections. NEOSONICS Our solution is quick, easy and cost-efficient screening for serous fluid infections by means of our first-in-class medical device Neosonics to non-invasively count white blood cells, a well-established diagnostic biomarker with clearly defined and internationally accepted clinical thresholds. In normal conditions, serous fluids have no, or very low white blood cell counts yet in case of infection the white blood cell level significantly increases within hours to respond to the attack of a pathogen. This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.